|
1
|
Mathers CD and Loncar D: Projections of
global mortality and burden of disease from 2002 to 2030. PLoS Med.
3(e442)2006.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hanania NA and Marciniuk DD: A unified
front against COPD: Clinical practice guidelines from the American
College of Physicians, the American College of Chest Physicians,
the American Thoracic Society, and the European Respiratory
Society. Chest. 140:565–566. 2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rabe KF, Hurd S, Anzueto A, Barnes PJ,
Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R,
van Weel C, et al: Global strategy for the diagnosis, management,
and prevention of chronic obstructive pulmonary disease: GOLD
executive summary. Am J Respir Crit Care Med. 176:532–555.
2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Aghapour M, Raee P, Moghaddam SJ, Hiemstra
PS and Heijink IH: Airway epithelial barrier dysfunction in chronic
obstructive pulmonary disease: Role of cigarette smoke exposure. Am
J Respir Cell Mol Biol. 58:157–169. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ng DS, Liao W, Tan WS, Chan TK, Loh XY and
Wong WS: Anti-malarial drug artesunate protects against cigarette
smoke-induced lung injury in mice. Phytomedicine. 21:1638–1644.
2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Murray LA, Dunmore R, Camelo A, Da Silva
CA, Gustavsson MJ, Habiel DM, Hackett TL, Hogaboam CM, Sleeman MA
and Knight DA: Acute cigarette smoke exposure activates apoptotic
and inflammatory programs but a second stimulus is required to
induce epithelial to mesenchymal transition in COPD epithelium.
Respir Res. 18(82)2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Huang AX, Lu LW, Liu WJ and Huang M:
Plasma inflammatory cytokine IL-4, IL-8, IL-10, and TNF-α levels
correlate with pulmonary function in patients with asthma-chronic
obstructive pulmonary disease (COPD) overlap syndrome. Med Sci
Monit. 22:2800–2808. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang C, Li Z, Liu X, Peng Q, Li F, Li D
and Wang C: Effect of Liuweibuqi capsule, a Chinese patent
medicine, on the JAK1/STAT3 pathway and MMP9/TIMP1 in a chronic
obstructive pulmonary disease rat model. J Tradit Chin Med.
35:54–62. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Marushchak M, Maksiv K and Krynytska I:
The specific features of free radical oxidation in patients with
chronic obstructive pulmonary disease and arterial hypertension.
Pol Merkur Lekarski. 47:95–98. 2019.PubMed/NCBI
|
|
10
|
Bateman ED, Hurd SS, Barnes PJ, Bousquet
J, Drazen JM, FitzGerald JM, Gibson P, Ohta K, O'Byrne P, Pedersen
SE, et al: Global strategy for asthma management and prevention:
GINA executive summary. Eur Respir J. 31:143–178. 2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Barnes PJ, Greening AP and Crompton GK:
Glucocorticoid resistance in asthma. Am J Respir Crit Care Med. 152
(Suppl):S125–S140. 1995.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Burmester GR and Pope JE: Novel treatment
strategies in rheumatoid arthritis. Lancet. 389:2338–2348.
2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Baumgart DC and Sandborn WJ: Inflammatory
bowel disease: Clinical aspects and established and evolving
therapies. Lancet. 369:1641–1657. 2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Torres J, Mehandru S, Colombel JF and
Peyrin-Biroulet L: Crohn's disease. Lancet. 389:1741–1755.
2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Dignass A, Van Assche G, Lindsay JO,
Lémann M, Söderholm J, Colombel JF, Danese S, D'Hoore A, Gassull M,
Gomollón F, et al: The second European evidence-based Consensus on
the diagnosis and management of Crohn's disease: Current
management. J Crohn's Colitis. 4:28–62. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rhen T and Cidlowski JA: Antiinflammatory
action of glucocorticoids-new mechanisms for old drugs. N Engl J
Med. 353:1711–1723. 2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Barnes PJ: New therapies for chronic
obstructive pulmonary disease. Med Princ Pract. 19:330–338.
2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Morjaria JB, Malerba M and Polosa R:
Biologic and pharmacologic therapies in clinical development for
the inflammatory response in COPD. Drug Discov Today. 15:396–405.
2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Barnes PJ: How corticosteroids control
inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol.
148:245–254. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rodriguez JM, Monsalves-Alvarez M,
Henriquez S, Llanos MN and Troncoso R: Glucocorticoid resistance in
chronic diseases. Steroids. 115:182–192. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Barnes PJ and Adcock IM: Glucocorticoid
resistance in inflammatory diseases. Lancet. 373:1905–1917.
2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cosio BG, Tsaprouni L, Ito K, Jazrawi E,
Adcock IM and Barnes PJ: Theophylline restores histone deacetylase
activity and steroid responses in COPD macrophages. J Exp Med.
200:689–695. 2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Barnes PJ, Ito K and Adcock IM:
Corticosteroid resistance in chronic obstructive pulmonary disease:
Inactivation of histone deacetylase. Lancet. 363:731–733.
2004.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhou Z, Zheng W, Liang T, Yan Q, Zhang C,
Huang H, Liu X and Ye X: Efficacy and safety of Chuankezhi
injection in patients with chronic obstructive pulmonary disease: A
systematic review and meta-analysis protocol. Medicine (Baltimore).
99(e18620)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhao YL, Song HR, Fei JX, Liang Y, Zhang
BH, Liu QP, Wang J and Hu P: The effects of Chinese yam-epimedium
mixture on respiratory function and quality of life in patients
with chronic obstructive pulmonary disease. J Tradit Chin Med.
32:203–207. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
He W, Sun H, Yang B, Zhang D and Kabelitz
D: Immunoregulatory effects of the herba Epimediia glycoside
icariin. Arzneimittelforschung. 45:910–913. 1995.PubMed/NCBI
|
|
27
|
Shi Y, Yan WH, Lin QY and Wang WM: Icariin
influences cardiac remodeling following myocardial infarction by
regulating the CD147/MMP-9 pathway. J Int Med Res. 46:2371–2385.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Dong H, Ming S, Fang J, Li Y and Liu L:
Icariin ameliorates angiotensin II-induced cerebrovascular
remodeling by inhibiting Nox2-containing NADPH oxidase activation.
Hum Cell. 32:22–30. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ming LG, Chen KM and Xian CJ: Functions
and action mechanisms of flavonoids genistein and icariin in
regulating bone remodeling. J Cell Physiol. 228:513–521.
2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Xu CQ, Liu BJ, Wu JF, Xu YC, Duan XH, Cao
YX and Dong JC: Icariin attenuates LPS-induced acute inflammatory
responses: Involvement of PI3K/Akt and NF-kappaB signaling pathway.
Eur J Pharmacol. 642:146–153. 2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chen SR, Xu XZ, Wang YH, Chen JW, Xu SW,
Gu LQ and Liu PQ: Icariin derivative inhibits inflammation through
suppression of p38 mitogen-activated protein kinase and nuclear
factor-kappaB pathways. Biol Pharm Bull. 33:1307–1313.
2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wu J, Xu H, Wong PF, Xia S, Xu J and Dong
J: Icaritin attenuates cigarette smoke-mediated oxidative stress in
human lung epithelial cells via activation of PI3K-AKT and Nrf2
signaling. Food Chem Toxicol. 64:307–313. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Krystosek A and Sachs L: Control of
lysozyme induction in the differentiation of myeloid leukemic
cells. Cell. 9:675–684. 1976.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hu L, Yu Y, Huang H, Fan H, Hu L, Yin C,
Li K, Fulton DJ and Chen F: Epigenetic regulation of interleukin 6
by histone acetylation in macrophages and its role in
paraquat-induced pulmonary Fibrosis. Front Immunol.
7(696)2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Papakonstantinou E, Karakiulakis G,
Batzios S, Savic S, Roth M, Tamm M and Stolz D: Acute exacerbations
of COPD are associated with significant activation of matrix
metalloproteinase 9 irrespectively of airway obstruction, emphysema
and infection. Respir Res. 16(78)2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Navratilova Z, Kolek V and Petrek M:
Matrix metalloproteinases and their inhibitors in chronic
obstructive pulmonary disease. Arch Immunol Ther Exp (Warsz).
64:177–193. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Vandewalle J, Luypaert A, De Bosscher K
and Libert C: Therapeutic mechanisms of glucocorticoids. Trends
Endocrinol Metab. 29:42–54. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Li J, Liu D, Wu J, Zhang D, Cheng B, Zhang
Y, Yin Z, Wang Y, Du J and Ling C: Ginsenoside Rg1 attenuates
ultraviolet B-induced glucocortisides resistance in keratinocytes
via Nrf2/HDAC2 signalling. Sci Rep. 6(39336)2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Stabile AM, Marinucci L, Balloni S,
Giuliani A, Pistilli A, Bodo M and Rende M: Long term effects of
cigarette smoke extract or nicotine on nerve growth factor and its
receptors in a bronchial epithelial cell line. Toxicol In Vitro.
53:29–36. 2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Munakata S, Ishimori K, Kitamura N,
Ishikawa S, Takanami Y and Ito S: Oxidative stress responses in
human bronchial epithelial cells exposed to cigarette smoke and
vapor from tobacco- and nicotine-containing products. Regul Toxicol
Pharmacol. 99:122–128. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Eisner MD, Anthonisen N, Coultas D,
Kuenzli N, Perez-Padilla R, Postma D, Romieu I, Silverman EK and
Balmes JR: Committee on Nonsmoking COPD Environmental and
Occupational Health Assembly. An official American Thoracic Society
public policy statement: Novel risk factors and the global burden
of chronic obstructive pulmonary disease. Am J Respir Crit Care
Med. 182:693–718. 2010.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lee H, Jung KH, Park S, Kil YS, Chung EY,
Jang YP, Seo EK and Bae H: Inhibitory effects of Stemona tuberosa
on lung inflammation in a subacute cigarette smoke-induced mouse
model. BMC Complement Altern Med. 14(513)2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Ramos CO, Campos KKD, Costa GP, Cangussú
SD, Talvani A and Bezerra FS: Taurine treatment decreases
inflammation and oxidative stress in lungs of adult mice exposed to
cigarette smoke. Regul Toxicol Pharmacol. 98:50–57. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Chen L, Ge Q, Tjin G, Alkhouri H, Deng L,
Brandsma CA, Adcock I, Timens W, Postma D, Burgess JK, et al:
Effects of cigarette smoke extract on human airway smooth muscle
cells in COPD. Eur Respir J. 44:634–646. 2014.PubMed/NCBI View Article : Google Scholar
|
|
46
|
BéruBé K, Aufderheide M, Breheny D,
Clothier R, Combes R, Duffin R, Forbes B, Gaça M, Gray A, Hall I,
et al: In vitro models of inhalation toxicity and disease The
report of a FRAME workshop. Altern Lab Anim. 37:89–141.
2009.PubMed/NCBI
|
|
47
|
López-Rodríguez JC, Benedé S, Barderas R,
Villalba M and Batanero E: Airway epithelium plays a leading role
in the complex framework underlying respiratory allergy. J Investig
Allergol Clin Immunol. 27:346–355. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Gras D, Chanez P, Vachier I, Petit A and
Bourdin A: Bronchial epithelium as a target for innovative
treatments in asthma. Pharmacol Ther. 140:290–305. 2013.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Pouli AE, Hatzinikolaou DG, Piperi C,
Stavridou A, Psallidopoulos MC and Stavrides JC: The cytotoxic
effect of volatile organic compounds of the gas phase of cigarette
smoke on lung epithelial cells. Free Radic Biol Med. 34:345–355.
2003.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Singh S, Verma SK, Kumar S, Ahmad MK,
Nischal A, Singh SK and Dixit RK: Correlation of severity of
chronic obstructive pulmonary disease with potential biomarkers.
Immunol Lett. 196:1–10. 2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Zhang X, Zheng H, Zhang H, Ma W, Wang F,
Liu C and He S: Increased interleukin (IL)-8 and decreased IL-17
production in chronic obstructive pulmonary disease (COPD) provoked
by cigarette smoke. Cytokine. 56:717–725. 2011.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Schneider D, Ganesan S, Comstock AT,
Meldrum CA, Mahidhara R, Goldsmith AM, Curtis JL, Martinez FJ,
Hershenson MB and Sajjan U: Increased cytokine response of
rhinovirus-infected airway epithelial cells in chronic obstructive
pulmonary disease. Am J Respir Crit Care Med. 182:332–340.
2010.PubMed/NCBI View Article : Google Scholar
|
|
53
|
de Godoy I, Donahoe M, Calhoun WJ, Mancino
J and Rogers RM: Elevated TNF-alpha production by peripheral blood
monocytes of weight-losing COPD patients. Am J Respir Crit Care
Med. 153:633–637. 1996.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Xie J, Yang XY, Shi JD, Deng XQ and Long
W: A new inflammation marker of chronic obstructive pulmonary
disease-adiponectin. World J Emerg Med. 1:190–195. 2010.PubMed/NCBI
|
|
55
|
Barnes PJ: Therapy of chronic obstructive
pulmonary disease. Pharmacol Ther. 97:87–94. 2003.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Wu H, Yang S, Wu X, Zhao J, Zhao J, Ning
Q, Xu Y and Xie J: Interleukin-33/ST2 signaling promotes production
of interleukin-6 and interleukin-8 in systemic inflammation in
cigarette smoke-induced chronic obstructive pulmonary disease mice.
Biochem Biophys Res Commun. 450:110–116. 2014.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Malaviya R, Laskin JD and Laskin DL:
Anti-TNFα therapy in inflammatory lung diseases. Pharmacol Ther.
180:90–98. 2017.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Zhang L, Cheng Z, Liu W and Wu K:
Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and
sputum of stable chronic obstructive pulmonary disease patients.
COPD. 10:459–465. 2013.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Pelegrino NR, Tanni SE, Amaral RA,
Angeleli AY, Correa C and Godoy I: Effects of active smoking on
airway and systemic inflammation profiles in patients with chronic
obstructive pulmonary disease. Am J Med Sci. 345:440–445.
2013.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Mercer PF, Shute JK, Bhowmik A, Donaldson
GC, Wedzicha JA and Warner JA: MMP-9, TIMP-1 and inflammatory cells
in sputum from COPD patients during exacerbation. Respir Res.
6(151)2005.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Yao H, Hwang JW, Sundar IK, Friedman AE,
McBurney MW, Guarente L, Gu W, Kinnula VL and Rahman I: SIRT1
redresses the imbalance of tissue inhibitor of matrix
metalloproteinase-1 and matrix metalloproteinase-9 in the
development of mouse emphysema and human COPD. Am J Physiol Lung
Cell Mol Physiol. 305:L615–L624. 2013.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Greenlee KJ, Werb Z and Kheradmand F:
Matrix metalloproteinases in lung: Multiple, multifarious, and
multifaceted. Physiol Rev. 87:69–98. 2007.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Tiede SL, Wassenberg M, Christ K,
Schermuly RT, Seeger W, Grimminger F, Ghofrani HA and Gall H:
Biomarkers of tissue remodeling predict survival in patients with
pulmonary hypertension. Int J Cardiol. 223:821–826. 2016.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Vogel ER, Britt RD Jr, Faksh A, Kuipers I,
Pandya H, Prakash YS, Martin RJ and Pabelick CM: Moderate hyperoxia
induces extracellular matrix remodeling by human fetal airway
smooth muscle cells. Pediatr Res. 81:376–383. 2017.PubMed/NCBI View Article : Google Scholar
|
|
65
|
MacDougall JR and Matrisian LM:
Contributions of tumor and stromal matrix metalloproteinases to
tumor progression, invasion and metastasis. Cancer Metastasis Rev.
14:351–362. 1995.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Yao PM, Buhler JM, d'Ortho MP, Lebargy F,
Delclaux C, Harf A and Lafuma C: Expression of matrix
metalloproteinase gelatinases A and B by cultured epithelial cells
from human bronchial explants. J Biol Chem. 271:15580–15589.
1996.PubMed/NCBI View Article : Google Scholar
|
|
67
|
LeBert DC, Squirrell JM, Rindy J,
Broadbridge E, Lui Y, Zakrzewska A, Eliceiri KW, Meijer AH and
Huttenlocher A: Matrix metalloproteinase 9 modulates collagen
matrices and wound repair. Development. 142:2136–2146.
2015.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Linder R, Rönmark E, Pourazar J, Behndig
A, Blomberg A and Lindberg A: Serum metalloproteinase-9 is related
to COPD severity and symptoms-cross-sectional data from a
population based cohort-study. Respir Res. 16(28)2015.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Chaudhuri R, McSharry C, Spears M, Brady
J, Grierson C, Messow CM, Miele G, Nocka K, MacNee W, Connell M, et
al: Sputum matrix metalloproteinase-9 is associated with the degree
of emphysema on computed tomography in COPD. Transl Respir Med.
1(11)2013.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Lambert E, Dassé E, Haye B and Petitfrère
E: TIMPs as multifacial proteins. Crit Rev Oncol Hematol.
49:187–198. 2004.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Toricelli M, Melo FH, Peres GB, Silva DC
and Jasiulionis MG: Timp1 interacts with beta-1 integrin and CD63
along melanoma genesis and confers anoikis resistance by activating
PI3-K signaling pathway independently of Akt phosphorylation. Mol
Cancer. 12(22)2013.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Arpino V, Brock M and Gill SE: The role of
TIMPs in regulation of extracellular matrix proteolysis. Matrix
Biol. 44-46:247–254. 2015.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Mocchegiani E, Giacconi R and Costarelli
L: Metalloproteases/anti-metalloproteases imbalance in chronic
obstructive pulmonary disease: Genetic factors and treatment
implications. Curr Opin Pulm Med. 17 (Suppl 1):S11–S19.
2011.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Pryor WA and Stone K: Oxidants in
cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and
peroxynitrite. Ann N Y Acad Sci. 686:12–27; discussion 27-28.
1993.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Boukhenouna S, Wilson MA, Bahmed K and
Kosmider B: Reactive oxygen species in chronic obstructive
pulmonary disease. Oxid Med Cell Longev.
2018(5730395)2018.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Jiang Y, Wang X and Hu D: Mitochondrial
alterations during oxidative stress in chronic obstructive
pulmonary disease. Int J Chron Obstruct Pulmon Dis. 12:1153–1162.
2017.PubMed/NCBI View Article : Google Scholar
|
|
77
|
MacNee W: Pulmonary and systemic
oxidant/antioxidant imbalance in chronic obstructive pulmonary
disease. Proc Am Thorac Soc. 2:50–60. 2005.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Barnes PJ: Mechanisms and resistance in
glucocorticoid control of inflammation. J Steroid Biochem Mol Biol.
120:76–85. 2010.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Ingawale DK, Mandlik SK and Patel SS: An
emphasis on molecular mechanisms of anti-inflammatory effects and
glucocorticoid resistance. J Complement Integr Med. 12:1–13.
2015.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Ito K, Yamamura S, Essilfie-Quaye S, Cosio
B, Ito M, Barnes PJ and Adcock IM: Histone deacetylase 2-mediated
deacetylation of the glucocorticoid receptor enables NF-kappaB
suppression. J Exp Med. 203:7–13. 2006.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Payne DN and Adcock IM: Molecular
mechanisms of corticosteroid actions. Paediatr Respir Rev.
2:145–150. 2001.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Ogawa S, Lozach J, Benner C, Pascual G,
Tangirala RK, Westin S, Hoffmann A, Subramaniam S, David M,
Rosenfeld MG and Glass CK: Molecular determinants of crosstalk
between nuclear receptors and toll-like receptors. Cell.
122:707–721. 2005.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Li L, Sun J, Xu C, Zhang H, Wu J, Liu B
and Dong J: Icariin ameliorates cigarette smoke induced
inflammatory responses via suppression of NF-κB and modulation of
GR in vivo and in vitro. PLoS One. 9(e102345)2014.PubMed/NCBI View Article : Google Scholar
|
